What We Do

Certificates of Analysis

Certificates of Analysis

Purification projects typically aim to deliver target compounds at ≥95% purity as assessed by HPLC-UV-MS/ELSD (evaporative light scattering detection). The material can also be analysed by 1H NMR spectroscopy to confirm purity and structural identity.

Certificates of Analysis can be supplied  incorporating use of quantitative NMR (qNMR) as a method for quantitation of content and purity.

If the target compounds are intended for use quantitatively as reference standards (such as quantitative bioanalysis or drug-drug interaction studies), Hypha would generally recommend additional physicochemical analyses to be performed to test for residual solvents, salt forms of the target compounds and residual inorganic impurities. The results would be summarised in the form of a higher-level Certificate of Analysis.

Key features

These additional analyses are outsourced to specialist contract service providers and most often include:

High resolution mass spectrometric analysis (HR-MS) to confirm accurate mass and empirical formula

Thermogravimetric analysis-FTIR (TGA-FTIR) to measure the amount of residual solvents including water

Karl Fischer analysis to measure water content.

Quantitative NMR (qNMR) to determine organic purity

Elemental analysis to determine C, H and N content

In total these analyses require ca. 35 mg of material per compound. Further physicochemical analyses are available and a full list can be provided on request.


Explore our library of resources comprising brochures, case studies, posters and publications about the work we do.

Access to multiple metabolites needed to support clinical development is not always straightforward, and can sometimes mean that more than one technique needs to be applied to fulfil requirements. In one such project, a US pharma client required > 200 mg of three metabolites of a drug; an N-glucuronide (M1), an indirect O-glucuronide (M2b) and a hydroxylated metabolite (M8b). As part of this project, multiple components of Hypha’s one-stop metabolite shop were employed, including chemical synthesis, microbial biotransformation as well as purification and structure elucidation by NMR.

If clearance mechanisms of the test drug results in sufficient quantities of the major metabolites in biological material such as faeces or urine, purification and subsequent identification of metabolites from such matrices is possible. One such project undertaken at Hypha resulted in tens of milligrams of the R- and S-O-glucuronides of carisbamate, a neuromodulator developed by SK Life Science, which were purified to >95% purity from 150 ml of urine using a three-step purification method.

In Chapter 4 of the book on “Identification and quantification of drugs, metabolites, drug metabolizing enzymes and transporters”, Hypha authors summarise the different methods employed for producing metabolites of drugs, illustrated with representative examples from the literature and work undertaken at Hypha. The chapter also includes a discussion and examples of the use of NMR spectroscopy for structure elucidation of metabolites.

Test tubes with dripper
251A3171-DE01-48EB-AA27-BD82BC5AC10DCreated with sketchtool.

Hypha Discovery came highly recommended and we subsequently contracted with Hypha to extract and purify metabolites out of rabbit urine. As they were so successful with that extraction, we again requested help for a second program to extract metabolites from human urine and/or synthesize/biosynthesize 3 metabolites. As expected, Hypha has been successful preparing these metabolite reference standards along with structural elucidation and certificates of analysis.

Head of Toxicology/DMPK

US Pharma company

Ready to begin? Our scientists are available to talk through your requirements

Contact Us 2

Don't forget to subscribe to our newsletter and blog!

Newsletter Signup
Which do you wish to signup for?